SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000078003-24-000029
Filing Date
2024-02-14
Accepted
2024-02-14 14:24:22
Documents
1
Group Members
PFIZER OTC B. V.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A CELLECTIS cellectisschedule13gaexitf.htm SC 13G/A 52214
  Complete submission text file 0000078003-24-000029.txt   53990
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013
Business Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013 33181691600
Cellectis S.A. (Subject) CIK: 0001627281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89356 | Film No.: 24636089
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)